Giulia Gramignano

2.9k total citations
40 papers, 2.1k citations indexed

About

Giulia Gramignano is a scholar working on Physiology, Oncology and Molecular Biology. According to data from OpenAlex, Giulia Gramignano has authored 40 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Giulia Gramignano's work include Nutrition and Health in Aging (10 papers), Biochemical Acid Research Studies (9 papers) and Vitamin C and Antioxidants Research (7 papers). Giulia Gramignano is often cited by papers focused on Nutrition and Health in Aging (10 papers), Biochemical Acid Research Studies (9 papers) and Vitamin C and Antioxidants Research (7 papers). Giulia Gramignano collaborates with scholars based in Italy, Japan and United States. Giulia Gramignano's co-authors include Clelia Madeddu, Antonio Macciò, Giovanni Mantovani, Maria Rita Lusso, Elena Massa, Giorgio Astara, Roberto Serpe, Carlo Mulas, C. Floris and Loredana Mura and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Giulia Gramignano

40 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giulia Gramignano Italy	24	696	559	546	296	269	40	2.1k
Thomas C. Wascher Austria	32	731 1.1×	972 1.7×	333 0.6×	91 0.3×	152 0.6×	112	3.0k
Maria Rita Lusso Italy	16	515 0.7×	374 0.7×	238 0.4×	238 0.8×	84 0.3×	20	1.3k
Hui Huang China	28	229 0.3×	870 1.6×	316 0.6×	143 0.5×	407 1.5×	187	2.7k
Peter Båvenholm Sweden	21	547 0.8×	877 1.6×	291 0.5×	106 0.4×	403 1.5×	27	2.7k
Hideki Hidaka Japan	26	424 0.6×	1.1k 1.9×	806 1.5×	255 0.9×	74 0.3×	108	3.1k
Óscar Beloqui Spain	34	471 0.7×	557 1.0×	199 0.4×	169 0.6×	185 0.7×	85	2.9k
Shusuke Yagi Japan	32	402 0.6×	1.0k 1.8×	248 0.5×	190 0.6×	162 0.6×	175	3.6k
Lija Joseph United States	25	566 0.8×	890 1.6×	235 0.4×	79 0.3×	313 1.2×	44	2.5k
Hirofumi Soejima Japan	35	359 0.5×	652 1.2×	171 0.3×	185 0.6×	435 1.6×	126	3.9k
Tetsuro Shishido Japan	36	519 0.7×	1.3k 2.3×	251 0.5×	217 0.7×	124 0.5×	149	4.0k

Countries citing papers authored by Giulia Gramignano

Since Specialization

Citations

This map shows the geographic impact of Giulia Gramignano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Gramignano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Gramignano more than expected).

Fields of papers citing papers by Giulia Gramignano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Gramignano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Gramignano. The network helps show where Giulia Gramignano may publish in the future.

Co-authorship network of co-authors of Giulia Gramignano

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Gramignano. A scholar is included among the top collaborators of Giulia Gramignano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Gramignano. Giulia Gramignano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madeddu, Clelia, Eleonora Lai, Manuela Neri, et al.. (2025). Association Between TP53 Mutations and Platinum Resistance in a Cohort of High-Grade Serous Ovarian Cancer Patients: Novel Implications for Personalized Therapeutics. International Journal of Molecular Sciences. 26(5). 2232–2232. 2 indexed citations

Madeddu, Clelia, Giulia Gramignano, Eleonora Lai, et al.. (2024). Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumors. ESMO Open. 9(10). 103738–103738. 1 indexed citations

Macciò, Antonio, et al.. (2020). Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients. Scientific Reports. 10(1). 6096–6096. 119 indexed citations

Madeddu, Clelia, Giulia Gramignano, Giorgio Astara, et al.. (2018). Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach. Frontiers in Physiology. 9. 1294–1294. 126 indexed citations

Madeddu, Clelia, Giovanni Mantovani, Giulia Gramignano, & Antonio Macciò. (2015). Advances in pharmacologic strategies for cancer cachexia. Expert Opinion on Pharmacotherapy. 16(14). 2163–2177. 24 indexed citations

Macciò, Antonio, Clelia Madeddu, Giulia Gramignano, et al.. (2014). The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study. Haematologica. 100(1). 124–132. 172 indexed citations

Madeddu, Clelia, et al.. (2014). A combined treatment approach for cachexia and cancer-related anemia in advanced cancer patients: A randomized placebo-controlled trial.. Journal of Clinical Oncology. 32(31_suppl). 189–189. 7 indexed citations

Macciò, Antonio, Clelia Madeddu, Giulia Gramignano, et al.. (2011). A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life. Gynecologic Oncology. 124(3). 417–425. 102 indexed citations

Macciò, Antonio, Clelia Madeddu, Giulia Gramignano, et al.. (2010). Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications. Journal of Molecular Medicine. 88(7). 677–686. 81 indexed citations

10.

Mantovani, Giovanni, Clelia Madeddu, Giulia Gramignano, et al.. (2007). An Innovative Treatment Approach for Cancer-Related Anorexia/Cachexia and Oxidative Stress: Background and Design of an Ongoing, Phase III, Randomized Clinical Trial. PubMed. 4(3). 163–167. 5 indexed citations

11.

Gramignano, Giulia, Maria Rita Lusso, Clelia Madeddu, et al.. (2006). Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition. 22(2). 136–145. 133 indexed citations

12.

Massa, Elena, Clelia Madeddu, Maria Rita Lusso, Giulia Gramignano, & Giovanni Mantovani. (2005). Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. Critical Reviews in Oncology/Hematology. 57(2). 175–182. 55 indexed citations

13.

Mantovani, Giovanni, Clelia Madeddu, Giulia Gramignano, et al.. (2004). Association of serum IL-6 levels with comprehensive geriatric assessment variables in a population of elderly cancer patients. Oncology Reports. 11(1). 197–206. 11 indexed citations

14.

Mantovani, Giovanni, Clelia Madeddu, Giulia Gramignano, et al.. (2003). Subcutaneous interleukin‐2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters. PubMed. 3(4). 205–219. 23 indexed citations

15.

Mantovani, Giovanni, Antonio Macciò, Clelia Madeddu, et al.. (2003). The Impact of Different Antioxidant Agents alone or in Combination on Reactive Oxygen Species, Antioxidant Enzymes and Cytokines in a Series of Advanced Cancer Patients at Different Sites: Correlation with Disease Progression. Free Radical Research. 37(2). 213–223. 84 indexed citations

16.

Mantovani, Giovanni, Antonio Macciò, Clelia Madeddu, et al.. (2003). Reactive Oxygen Species, Antioxidant Mechanisms, and Serum Cytokine Levels in Cancer Patients: Impact of an Antioxidant Treatment. Journal of Environmental Pathology Toxicology and Oncology. 22(1). 17–28. 45 indexed citations

17.

Mantovani, Giovanni, Elena Massa, Giorgio Astara, et al.. (2003). Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs. Oncology Reports. 10(1). 197–206. 29 indexed citations

18.

Mantovani, Giovanni, Clelia Madeddu, Loredana Mura, et al.. (2003). Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. Journal of Molecular Medicine. 81(10). 664–673. 97 indexed citations

19.

Mantovani, Giovanna, Antonio Macciò, Clelia Madeddu, et al.. (2002). Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment. Journal of Cellular and Molecular Medicine. 6(4). 570–582. 63 indexed citations

20.

Mantovani, Giovanni, Antonio Macciò, Clelia Madeddu, et al.. (2001). Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites. Journal of Molecular Medicine. 79(7). 406–414. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact